# Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

> **NCT01091454** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 48 (actual)

## Conditions studied

- Triple-negative Breast Cancer

## Interventions

- **DRUG:** brostallicin
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT01091454
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-06
- **Final completion:** 2014-11-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2018-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01091454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01091454, "Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01091454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*